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Background: Congenital thoracic malformations (CTM) are rare lung lesions that are managed with surgical
resection or active surveillance.
The objective of this study was to comprehensively assess large and small airway function in children with CTM
who underwent lobectomy in early life.
We hypothesise that sensitive measures of lung function will demonstrate residual impairments in CTM compared
to healthy children.
Methods: Nitrogen lung clearance index (LCI), reactance and resistance (X5Hz and R5Hz), forced expiratory
volume in 1 s and forced vital capacity (FEV1 and FVC) were prospectively measured in 10 children with
CTM (mean age/SD: 7.6/1.3) who had undergone surgical resection in early life and in 17 healthy children
(mean age/SD: 4.8/0.4). Total lung capacity (TLC) was also conducted in children older than 7 years of age
with CTM (n = 8).
Results: Mean LCI was 8.0 (95% CI 7.5 to 8.5) in the CTM group and 7.3 (95% CI 7.0 to 7.6) in
healthy children (p = 0.016). Mean X5Hz was −0.44kPa/l/s (95% CI −0.58 to −0.31) in the CTM group
and −0.31kPa/l/s (95% CI −0.35 to −0.27) in healthy children (p = 0.02). Mean Z score for X5Hz was −2.11
(95% CI −3.59 to −0.63) in the CTM group and −0.11 (95% CI −0.55 to 0.33) in healthy children (p = 0.0008). Mean
FEV1 was 1.21 L (95% CI 0.97 to 1.45) in the CTM group and 1.02 L (95% CI 0.90 to 1.15) in healthy children
(p = 0.22). Mean % predicted FEV1 was 83% (95% CI 74 to 92) in the CTM group and 97% (95% CI 87 to 107) in
healthy children (p < 0.05). Mean % predicted TLC in CTM children was 121.3% (95% CI 88.45 to 154.1). Mean LCI
was inversely correlated with height z-scores in the CTM group (rs = −0.88, p = 0.002) but not in healthy children
(rs = 0.22, p = 0.4).
Conclusions: Children with CTM have impaired lung function as demonstrated by the significant differences in
LCI, reactance and FEV1 but not FVC, resistance and TLC. These findings may be of clinical relevance as ventilation
inhomogeneities are closely correlated with somatic growth in this study.
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Congenital cystic adenomatoid malformations (CCAM)
are rare with an incidence of about one case per 10,000
to 35,000 births [1]. CCAMs have been classified trad-
itionally by histological classification given by Stocker
with three types (I, II and III) and the addition of type 0
and type IV subsequently [2]. CCAM type I are macro-
cystic, type II are microcystic and often associated with
multiple congenital anomalies, type III are solid, type 0
have bilateral involvement and type IV have an associ-
ation with pleuropulmonary blastoma. A new termin-
ology for CCAM was subsequently also suggested by
Stocker (congenital pulmonary airway malformation
(CPAM)) [3]. Most recently the term congenital thoracic
malformations (CTM) was coined by Bush [4] to include
a spectrum of lung lesions that are macroscopically
often indistinguishable, namely CCAM, sequestration,
congenital lobar emphysema, enteric and bronchogenic
cysts, and bronchial atresia but excludes congenital dia-
phragmatic hernia.
The prognosis of CTM is highly variable as deter-
mined by multiple factors including size of lung mass,
presence of lung hypoplasia, polyhydramnios, medias-
tinal shift, and fetal hydrops. While many of the cystic
lung lesions regress in-utero, some fail to do so. The
cystic lung lesions have been controversial in terms of
nomenclature, mechanism of pathogenesis and classifi-
cation of lesions. In regards to approaches to management
there exists consensus regarding surgical intervention
in cases with fetal hydrops and in symptomatic new-
borns with CTM.
In non-operated cases, there is a risk of sudden en-
largement of cysts, infections, pneumothorax and ma-
lignancy. In particular CCAM type II is associated with
the development of pleuropulmonary blastoma, while
rhabdomyosarcoma, myxosarcoma, and bronchioloal-
veolar carcinoma have been observed in CCAM tissue
[4]. Early surgery for CTM is recommended by some
authors given the above risks. However malignant
transformation remains uncommon and may occur
months after surgical resection [5-7]. Consensus is also
lacking regarding appropriate monitoring for malig-
nancies in non-resected CTM subjects.
Notably the natural history of CTM is not very well
documented, and hence it is difficult to determine its
most appropriate management. In fact data on long-
term respiratory outcomes in children with CTM is
scarce. Dysanaptic growth of the remaining lung tissue
has been described following resection of congenital
lung lesions in humans and post-pneumonectomy in
animals by mechanisms of alveolar distention and neo-
vascularization with new alveolar formation while the
conducting (small/peripherial) airways do not participate
equally [8,9]. The potential consequences include increasein airways resistance, change in elastic recoil properties
of the lung tissue, and the occurrence of ventilation
inhomgeneities. However, normal lung function, as
measured by spirometry, has been reported in children
with CTM resected in early life [10].
The peripheral, or small airways defined as conducting
airways that are less than 2 mm in internal diameter and
extend from the noncartilaginous bronchioles to the
alveolar ducts are anatomically connected to the regen-
erating alveolar compartment, hence abnormalities in
lung function associated with resected CTM is more
likely to represent peripheral airway abnormalities. The
peripheral airways are the predominant site of gas mix-
ing within the lungs, and account for 95% of the total
lung volume [11]. However, these airways are largely ig-
nored by spirometry, which measure bulk airflow and
predominantly reflect more central airway function [12].
As a result spirometry indices such as FEV1 can remain
normal despite marked involvement of the peripheral
airways in disease processes.
Recently, other physiological measures of lung func-
tion, possibly more sensitive, have become available and
are validated in children. Multiple breath washout
(MBW) is a non-invasive tidal breathing test, which
assesses the gas mixing efficiency within the lungs [13],
several studies have confirmed the superior sensitivity
of MBW tests to detect these changes in important
paediatric respiratory diseases [11]. Impulse oscillometry
(IOS) evaluates the mechanical properties of the respira-
tory system during tidal breathing. Airway diameter with
changes in lung volume, or so-called airway distensibility
is reflected by reactance, and changes in airway pressure
with lung volume by resistance. IOS has been demon-
strated to detect small changes in pulmonary function in
children with mild asthma and eosinophilic bronchitis,
which were undetected by spirometry [14]. The lung
growth post resection of CTM in humans may not be
entirely normal and the dysanaptic growth may be
reflected by changes in airway mechanics.
MBW and IOS are emerging as powerful tools in the
early detection of pulmonary function in children unable
to perform a maximal forced expiration [15,16]. Based
on these findings, we have employed nitrogen MBW and
IOS to determine if following lobectomy, residual abnor-
malities are present at school age in children with CTM
compared to healthy controls.
Methods
Population
The study involved 10 children recruited from our
surgical database who had undergone surgery for sus-
pected CTM in early life at the Newcastle Children’s
Hospital and 17 healthy children without a diagnosis
of asthma, current or previous CTM or any chronic
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“asthma ever” was assessed in a standardised question-
naire [17] and a diagnosis of “doctor’s diagnosis of
asthma” by a standardised parent interview. The study
was approved by the Hunter New England Research
Ethics Committee and written informed consent was
obtained from parents or legal guardians before inclu-
sion into the study.
Study design
Participants performed lung function testing on the
same day beginning with nitrogen MBW, followed by
IOS and spirometry. Skin prick testing to common in-
haled allergens was also performed to assess the atopic
nature of participants. In those children old enough we
preformed lung volumes (>7 years).
Measurement of lung function
Nitrogen MBW was performed using recently validated com-
mercial MBW (Exhalyzer D, EcoMedics AG, Switzerland),
which is an open circuit, bias flow system along with
associated software (Spiroware 3.1 EcoMedics AG,
Switzerland). N2 concentration is calculated indirectly
by measuring O2 and CO2 concentration (Capnostat 5,
Philips Healthcare, The Netherlands) simultaneously.
The participant breathed in 100% oxygen during wash-
out until N2 concentration was reduced to at least 1/40 th
of the initial concentration [18]. During testing the
patient was closely monitored for any signs of leak.
The test was performed in a seated position whilst
watching a movie to encourage stable tidal breathing.
The switch from room air to 100% oxygen was ma-
nually activated following an acceptable stable tidal
breathing pattern and end-expiratory lung volume, in
accordance with recent consensus. LCI was reported
as the mean of at least two acceptable tests within 10%
of each other [18].
IOS measurements (MasterScreen system, Jaeger Co,
Wuerzberg, Germany) were made according to ERS task
force recommendations [19]. The child was asked to
breathe in a relaxed manner whilst seated in an upright
position with a nose clip in place, while both cheeks
and the tongue base were supported with two hands by
the operator. Mean reactance and resistance were calcu-
lated over a measurement period of 30 seconds using
CareFusion software (CareFusion, Australia) at frequen-
cies of 5 Hz (R5Hz and X5Hz, respectively). The pre-
dicted value of at least two reproducible replicates
(coefficient of variation of at least 2 sets of data < 10%)
[20] were reported using published reference data [21].
Spirometry (MasterScreen system, Jaeger Co, Wuerzberg,
Germany) was conducted in accordance to ATS/ERS
guidelines [22] using the global lung initiative (GLI)
of 2012 [23].Skin prick allergy test
Skin prick testing was conducted using standard extract
for environmental allergens (house dust mites, cat and dog
dander, rye grass, 12 grass mix), 1:10 w/v (Stallergènes®,
Antony, France). A positive result was defined as 3 mm
or greater than negative saline control, determined by
averaging maximal perpendicular wheal diameters
15 minutes after applying the lancet. Positive control
was with histamine base, 6 mg/ml (Stallergènes®, Antony,
France) and had to be 3 mm or greater for a valid test.
Participants were asked to withhold any antihistamines
for three days prior to the test.
Statistical analysis
Statistical significance was determined using a non-
parametric, two-tailed Mann–Whitney U-test or the
parametric t-test as appropriate. Correlation analyses
were performed using a nonparametric Spearman’s test.
Age-adjusted height and weight z-scores were calculated
using the 2000 Centres for Disease Control and Preven-
tion Growth Charts [24]. We aimed for a participation
of at least 9 children per group to detect a mean differ-
ence of 1.5 SD in LCI (80% power, α = 5%) between the
groups, which we defined as clinically relevant.
Results
17 children with CTM were identified in our medical
record database but 5 families were not contactable. 10
of the 12 contacted parents agreed to participate (par-
ticipation rate 83%) while one family declined and one
child lived too distant to attend. All children performed
spirometry and MBW while IOS were unsuccessful in 2
patients due to instrument error. Results are compared
to data from 17 healthy children participating in an on-
going longitudinal study [25]. MBW and spirometry was
successful in 16 and IOS in 17 healthy children. The age
range in healthy children was 4 to 5 years and in chil-
dren from the CTM group 5 to 9 years (Table 1). Thus
children from the control group were slightly lighter and
shorter, however did not differ in their age-adjusted
weight and height Z-scores from children with CTM
(Table 1). Four of 10 children from the CTM group had
a doctor’s diagnosis of asthma and had documented
salbutamol use, but none in the group of healthy chil-
dren as per inclusion criteria (Table 1). As expected,
more CTM children had wheeze ever (70%) when com-
pared to healthy children (24%; p = 0.04) while there was
no significant difference in the prevalence of other
respiratory symptoms (Additional file 1: Table S1).
When comparing lung function values, children from
the CTM group had a significantly higher lung clearance
index (LCI), and lower FEV1% predicted and reactance
(X5Hz) Z score values (Table 2 and Figure 1a to c).
However airway resistance (R5Hz), FVC% predicted and
Table 1 Demographic details






Age 7.6 (1.3) 4.8 (0.4) <0.01
Male 4 (40%) 4 (24%) 0.41
Mean weight (kg) 24.9 (6.3) 18.7 kg (2.1) ND
Mean height (cm) 123.4 (10.1) 108.6 (4.0) ND
Mean Z score weight −0.2 (1.2) 0.4 (1.0) 0.16
Mean Z score height −0.3 (1.9) 0.5 (0.9) 0.06
Prematurity (<37 completed weeks) 3 (30%) 1 (6%) 0.13
Bronchiolitis in infancy 2 (20%) 2 (12%) 1.0
Asthma 4 (40%) None as per inclusion criteria NA
Eczema 4 (40%) 3 (18%) 1.0
Allergic rhinitis 1 (10%) 2 (12%) 0.56
Positive skin prick test 1 (10%) 1 (6%) 1.0
Not applicable (NA), not determined (ND).
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measured in the healthy control group (Table 2). The
CTM group showed lower functional residual cap-
acity (FRC) values (Figure 2a) as they were younger
but this was not evident if FRC was corrected for
weight (Figure 2b). The cumulative expired volume
(CEV) was higher in the CTM group (Figure 2c).
The details of pulmonary function tests of the CTM
group along with histopathological diagnosis and som-
atic growth parameters are given in Table 3. The details
of pulmonary function tests of the control group are
given in Additional file 1: Table S2. The mean % pre-
dicted total lung capacity (TLC) of children with CTM
was 121.3% (95% CI 88.45 to 154.1). If only non-
asthmatic CTM children were included in the analysis
there remained a significant difference in LCI (difference





Mean LCI 8.0/0.7 (10) 10
Mean FRC 1.11 10
Spirometry
Mean FEV1 (%predicted) 83.0/12.7 10
Mean FVC (%predicted) 94.2/16.2 10
Mean FEV1/FVC (%predicted) 88.4/11.0 10
Mean TLC (%predicted) 121.3/39.2 8
Impulse Oscillometry
Mean X5Hz (Z score) −2.11/1.768 8
Mean R5Hz (Z score) 1.45/1.77 8predicted: 61.2%; 95% CI 31.7 to 90.7, p = 0.0003) but
not FEV1% (difference in % predicted: 7.1%; 95% CI −9.6
to 23.8, p = 0.39) as compared to healthy children.
Interestingly a significant inverse correlation between
age-adjusted height Z-scores and LCI was observed in
children from the CTM cohort but not in healthy chil-
dren (Figure 1d). This correlation remained even when
the outlier was excluded (data not shown). This was nei-
ther the case for weight Z scores nor weight and height
not adjusted for age or any other lung function parame-
ters (data not shown).
Discussion
Our study reveals –for the first time– unevenness of
ventilation distribution (elevated LCI) in children who
were born with a CTM and underwent lobectomy in










Figure 1 Lung function results of children with CTM and healthy controls: a) LCI, b) reactance Z scores, c) FEV1% predicted, d) correlation
between LCI and age-adjusted height Z scores in children with CTM compared to healthy children.
Mandaliya et al. BMC Pulmonary Medicine  (2015) 15:25 Page 5 of 9relevance as they impair gas exchange efficiency and can
detrimentally affect the distribution of inhaled medica-
tions [26]. Notably unevenness of ventilation distribution
was also greater in those children who showed poorer
outcomes in somatic growth. We also observed increased
reactance in children with CTM suggesting abnormalFigure 2 N2 MBW lung volumes in children with CTM and healthy conelastic recoil, a pattern observed in lung fibrosis and
potentially associated with peripheral airway obstruc-
tion and small lungs [27].
Only a few studies have been published so far focusing
on long-term lung function outcomes in children who
had surgery for CTM in early life and they employedtrols: a) FRC (L), b)FRC (ml/kg), c) CEV (L).
Table 3 Details on histopathology and lung function in children with CTM and resection in early life




LCI FRC (L) FEV1% pred FVC % pred TLC % pred R5Hz Zscore X5Hz Zscore
9.5/F Y LUL Bronchial atresia + CCAM 36 1.7 6.9 1.46 88 91 211 X X
7.3/F N RLL CCAM Type III 2.5 −1.4 8.6 0.93 92 89 110 −0.18 −0.21
9.0/F N LUL CCAM Type II/III 9 −2.4 8.9 1.06 90 125 128 1.34 −1.91
6.2/M N LLL Intralobar sequestration 15 −0.7 8.7 0.73 81 85 X 1.53 −2.52
7.4/M N RLL Congenital sequestration 9 −0.7 8.0 1.04 82 95 77 0.82 −2.26
6.9/M N LUL Mixed type CCAM 0.5 1.0 7.6 1.20 100 113 108 X X
8.2/F Y RLL CCAM type IV 0.3 −1.6 8.6 1.06 59 74 119 5.05 −5.98
9.0/F N LLL Intralobar sequestration 9.5 −0.5 7.1 1.44 95 104 102 2.55 −2.13
7.4/M Y RUL Unclassified CTM 13 0.4 7.8 1.51 69 94 115 -.067 −0.52
5.7/F Y RLL CCAM type II/III 0.3 0.6 7.5 0.70 75 73 X 1.17 −1.38
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mine airflow limitation and lung volumes. For instance,
Naito et al. [28] performed spirometry, lung volumes
and exercise testing in 28 children who underwent
lobectomy at mean age of 13 months and found no im-
pairment in FEV1, FVC and total lung capacity (TLC)
and exercise capacity. Beres et al. [10] followed-up 15
children who had undergone surgery for suspected
CTM in infancy. They concluded that children under-
going lung resection in infancy have normal pulmonary
function tests with almost complete recovery post-
surgery due to compensatory lung growth except for
those with asthma who were found to have lower FEV1.
Caussade et al. [29] performed spirometry in 8 patients
who underwent lung surgery at mean age of 7.5 years
for congenital as well as acquired pulmonary condi-
tions and described normal FVC values. Postpneumo-
nectomy compensatory lung growth occurs in children
but it is unclear whether it recapitulates normal lung
growth. A longitudinal follow-up study by Nakajima
et al. [30] on 27 operated children with CTM found
decreased FVC and increased RV/TLC in the early post-
operative period, which recovered within 2 years, leading
to the conclusion that alveolar multiplication rather than
distension was responsible for the compensatory lung
growth in the long term. The lack of healthy control
groups however is a limitation in these studies.
We have conducted the most comprehensive lung
function studies yet in children with CTM and have
compared them to a healthy control group employing
identical methodology. While our study also found no
difference in FVC values, children with CTM show
impaired FEV1 values but only those with asthma as de-
scribed previously by Beres et al. [10]. Thus impaired
FEV1 values likely represent medium to large airways
disease involvement due to asthma in CTM children.
TLC in CTM children was above 100% predicted in 7
out of 8 measured (Table 3), These findings suggest that
compensatory growth has allowed, in terms of lung
volume, full recovery from lobectomy in early life and
excludes restrictive lung disease as a consequence of
CTM and/or lung surgery. Higher LCI and reactance in
CTM patients may be observed independent of asthma
and may be related to dysanaptic lung growth after
lobectomy. Alternatively, abnormal lung growth may be
a previously unrecognised feature of CTM. This latter
hypothesis is difficult to test as the radiologically normal
appearing lung surrounding the CTM lesion cannot be
investigated functionally in isolation in non-operated
CTM children.
The elevated LCI found in children with CTM demon-
strates a strong inverse correlation between LCI and
age-adjusted height. It is therefore possible that ventilation
inhomogeneities in children with CTM - indicated bythe higher LCI score- may be causally associated with
poorer outcomes in somatic growth. However longi-
tudinal studies starting in early life are required to con-
firm this speculation because the association between
LCI and somatic growth may be a surrogate marker for
other adverse health effects (e.g. lung infections) mani-
festing more commonly in CTM patients. A previous
study compared somatic growth of children operated in
infancy versus those operated in childhood, arriving at a
conclusion that children with earlier surgery had poorer
outcomes in terms of height (and weight) as compared
to the ones operated in childhood [31]. However lung
function was not determined in that study. Our results
suggest that unevenness of ventilation distribution as
indicated by elevated LCI is closely related to poorer
outcomes in somatic growth. It has yet to be deter-
mined however whether a close association between
LCI and somatic growth can also be found in other
disease groups where LCI has emerged as a highly sensi-
tive, age-independent measure of airway dysfunction
[32-36]. Further studies are required to determine
whether increases in LCI are prevented by optimal
nutritional intervention or whether they directly result
in poorer outcomes in somatic growth.
Our study has several limitations. Firstly, all children
with CTM underwent surgical resection in early life
precluding us from investigating the effects of this inter-
vention (as compared to non-surgical management) on
lung function outcomes. While these studies are on-
going, we believe it is unlikely that LCI and reactance
will be unaffected by a large non-resected CTM -even if
asymptomatic- thereby reducing any possible difference
in those parameters between operated and non-operated
children with CTM. Secondly, our cohort of healthy
children is slightly younger than the CTM cohort. How-
ever, given the relationship between height and LCI in
early childhood (LCI decreases with increasing height
before the age of six years), this difference in age may
have resulted –if anything– in an underestimation of the
difference between the groups. Lastly, as expected for a
rare disease our case numbers are low and our study
was powered to only observe a large effect size and
unable to detect smaller differences in other lung function
parameters. Previous studies found a difference in LCI
of one standard deviation between healthy and asthmatic
children (and children with multiple trigger wheeze)
[37]. The elevated LCI found in children with CTM
demonstrates a strong inverse correlation between LCI
and age-adjusted height. Although a pilot study we sug-
gest ventilation inhomogeneities in children with CTM,
indicated by the higher LCI score is associated with
poorer outcomes in somatic growth.
Based on these findings we suggest that nitrogen
MBW and IOS should be considered as sensitive tools
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CTM. Additionally both these tests have strong feasibil-
ity in preschool children. Our study reveals –for the first
time– residual ventilation inhomogeneities in children
with CTM who underwent lung resection in early life
which was most pronounced in those with poorer out-
comes in somatic growth. The strong inverse correlation
between LCI (but not any other lung function param-
eter) and age-adjusted height in children with CTM but
not healthy children suggests an unexpected association
between ventilation inhomogeneities which requires fur-
ther investigations in other chronic lung disease.
Conclusions
This study suggests that the measures of peripheral air-
way function are abnormal in children with CTM, even
though the lesion was removed surgically in early life.
The study population is small and further studies are re-
quired to gather more evidence. The functional impact
of the statistically significant differences in pulmonary
function also need to be assessed by future studies to
determine if these differences are clinically relevant.
Additional file
Additional file 1: Table S1. ISAAC questionnaire comparing the
respiratory health of CTM v healthy children. Table S2. Details on the
lung function of the healthy cohort of children.
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